Skip to main content

Table 2 Overview of patients

From: Customizable orthopaedic oncology implants: one institution’s experience with meeting current IRB and FDA requirements

Pt

Age

Diagnosis

Location

Surgery

Days to IRB approval

Days to FDA approval

Days to Sx

1

19

Ewing Sarcoma

Distal Femur

Revision

13

19

44

2

21

Ewing Sarcoma

Pelvis

Revision

18

7

35

3

11

Osteosarcoma

Distal Femur

Revision

7

15

12

4

13

Osteosarcoma

Prox Humerus

Revision

10

19

15

5

7

Osteosarcoma

Prox Tibia

Primary

12

7

28

6

11

Osteosarcoma

Prox Humerus

Primary

21

11

8

7

8

Osteosarcoma

Distal Femur

Primary

9

7

15

8

8

Osteosarcoma

Prox Humerus

Primary

21

15

4